Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule Level

被引:19
作者
Proszek, Joanna [1 ]
Roy, Amit [2 ,3 ]
Jakobsen, Ann-Katrine [1 ]
Frohlich, Rikke [2 ]
Knudsen, Birgitta R. [2 ]
Stougaard, Magnus [1 ]
机构
[1] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark
[3] Natl Inst Pharmaceut Educ & Res NIPER, Dept Biotechnol, Hajipur 844101, Bihar, India
来源
SENSORS | 2014年 / 14卷 / 01期
关键词
Topoisomerase-I; camptothecin; enzyme activity; biosensor; tyrosyl-DNA phosphodiesterase 1; single molecule; drug response; cancer; GASTRIC-CANCER; PROTEIN-KINASE; CELL-LINES; DNA; CAMPTOTHECIN; SENSITIVITY; PHOSPHORYLATION; IRINOTECAN; MECHANISM; CPT-11;
D O I
10.3390/s140101195
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Human topoisomerase I (hTopI) is an essential cellular enzyme. The enzyme is often upregulated in cancer cells, and it is a target for chemotherapeutic drugs of the camptothecin (CPT) family. Response to CPT-based treatment is dependent on hTopI activity, and reduction in activity, and mutations in hTopI have been reported to result in CPT resistance. Therefore, hTOPI gene copy number, mRNA level, protein amount, and enzyme activity have been studied to explain differences in cellular response to CPT. We show that Rolling Circle Enhanced Enzyme Activity Detection (REEAD), allowing measurement of hTopI cleavage-religation activity at the single molecule level, may be used to detect posttranslational enzymatic differences influencing CPT response. These differences cannot be detected by analysis of hTopI gene copy number, mRNA amount, or protein amount, and only become apparent upon measuring the activity of hTopI in the presence of CPT. Furthermore, we detected differences in the activity of the repair enzyme tyrosyl-DNA phosphodiesterase 1, which is involved in repair of hTopI-induced DNA damage. Since increased TDP1 activity can reduce cellular CPT sensitivity we suggest that a combined measurement of TDP1 activity and hTopI activity in presence of CPT will be the best determinant for CPT response.
引用
收藏
页码:1195 / 1207
页数:13
相关论文
共 40 条
  • [1] CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I-DNA Binding, and Increases Cellular Camptothecin Sensitivity
    Bandyopadhyay, Keya
    Li, Pingchuan
    Gjerset, Ruth A.
    [J]. PLOS ONE, 2012, 7 (11):
  • [2] Protein Kinase CK2 Is a Central Regulator of Topoisomerase I Hyperphosphorylation and Camptothecin Sensitivity in Cancer Cell Lines
    Bandyopadhyay, Keya
    Gjerset, Ruth A.
    [J]. BIOCHEMISTRY, 2011, 50 (05) : 704 - 714
  • [3] TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
    Barthelmes, HU
    Habermeyer, M
    Christensen, MO
    Mielke, C
    Interthal, H
    Pouliot, JJ
    Boege, F
    Marko, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55618 - 55625
  • [4] Bittoni A, 2010, EUR REV MED PHARMACO, V14, P309
  • [5] Characterization of the topoisomerase I locus in human colorectal cancer
    Boonsong, A
    Marsh, S
    Rooney, PH
    Stevenson, DAJ
    Cassidy, J
    McLeod, HL
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 56 - 60
  • [6] DNA topoisomerases: Structure, function, and mechanism
    Champoux, JJ
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 369 - 413
  • [7] PHOSPHORYLATION SITES FOR TYPE-N-II PROTEIN-KINASE IN DNA TOPOISOMERASE-I FROM CALF THYMUS
    CODERONI, S
    PAPARELLI, M
    GIANFRANCESCHI, GL
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1990, 22 (07): : 737 - 746
  • [8] Proteomic analysis of complexes formed by human topoisomerase I
    Czubaty, A
    Girstun, A
    Kowalska-Loth, B
    Trzcinska, AA
    Purta, E
    Winczura, A
    Grajkowski, W
    Staron, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1749 (01): : 133 - 141
  • [9] DARPA P, 1990, CANCER RES, V50, P6919
  • [10] Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma A Multicenter Experience of the Gruppo Oncologico Italia Meridionale
    Gebbia, Vittorio
    Maiello, Evaristo
    Giuliani, Francesco
    Borsellino, Nicolo
    Arcara, Carlo
    Colucci, Giuseppe
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 461 - 464